We are live on ! Find out more
QNME icon

Quanome Technologies

0.3402 USD
+0.0190
5.92%
At close Updated Nov 10, 4:00 PM EST
Pre-market
After hours
0.3678
+0.0276
8.11%
1 day
5.92%
5 days
-19.19%
1 month
-39.26%
3 months
-27.68%
6 months
-46.99%
Year to date
-61.78%
1 year
-66.32%
5 years
-91.52%
10 years
-91.52%
 

About: Quanome Technologies Inc operates in the midstream segment of the pharmaceutical industrial ecosystem, operating between upstream pharmaceutical manufacturers and downstream medical end customers. It sources products from multiple manufacturers and suppliers, and distribute them to hospitals, pharmaceutical distributors and other healthcare providers. Its principal product categories include infusion products, foods for special medical purposes, and specialty pharmaceuticals. It operates in one reportable segment serves its customers by providing pharmaceutical products in China. The company generates a substantial percentage of its revenue from selling pharmaceutical products on a direct basis.

Employees: 27

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 14.3%
Neutral 85.7%
Negative 0%
Neutral
GlobeNewsWire
2 days ago
Quanome Enters into Agreement for Strategic Investment in QAI Labs, Advancing Quantum Life Sciences Strategy
All-stock transactions will give Quanome approximately 5% stake in QAI Labs, the developer of NOVA-3, an AI-enabled platform designed for multi-specific antibody discovery New York, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Quanome Technologies, Inc. (Nasdaq: QNME) ("Quanome" or the "Company") today announced that it has entered into a definitive agreement, dated November 4, 2026, for its strategic investment in QAI Labs Ltd. ("QAI Labs" or "QAI"), an early-stage life sciences technology company developing NOVA-3, an AI-enabled discovery platform designed to combine quantum-computing algorithms (run on classical simulators) with laboratory testing to advance multi-specific antibody candidates.
Quanome Enters into Agreement for Strategic Investment in QAI Labs, Advancing Quantum Life Sciences Strategy
Neutral
GlobeNewsWire
13 days ago
Quanome Receives US$13.5 Million Customer Service Prepayment for Dedicated AI Inference Services; First Major Financial Milestone Under New AI Computing Business
First Cash Milestone Payment Under 60-Month Enterprise Order Supports Procurement and Build-Out of Dedicated AI Computing Capacity NEW YORK, NY, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Quanome Technologies, Inc. (Nasdaq: QNME) (“Quanome” or the “Company”) today announced that XDT Infrastructure I, LLC (“XDT”), an indirect wholly-owned subsidiary of Quanome, has received its first milestone payment in the amount of US$13.5 million from an enterprise customer. The payment is the first customer payment toward the prepayment disclosed in Quanome's Current Report on Form 8-K filed on October 5, 2026.
Quanome Receives US$13.5 Million Customer Service Prepayment for Dedicated AI Inference Services; First Major Financial Milestone Under New AI Computing Business
Neutral
GlobeNewsWire
1 month ago
Quanome's XDT Secures First Enterprise Customer Agreement for Dedicated AI Inference Services
Initial 60-Month Order Has a Total Commitment Value Exceeding $100 Million; Service-Start Conditions Apply New York, NY, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Quanome Technologies, Inc. (Nasdaq: QNME) (“Quanome” or the “Company”) today announced that XDT Infrastructure I, LLC (“XDT”), an indirect wholly-owned subsidiary of Quanome, has entered into a Master Services Agreement and initial Order with an enterprise customer to provide dedicated artificial intelligence capacity. Under the initial Order, XDT will provide the customer with dedicated computing capacity to run its AI applications.
Quanome's XDT Secures First Enterprise Customer Agreement for Dedicated AI Inference Services
Neutral
GlobeNewsWire
1 month ago
Quanome CEO to Back Quantum Strategy with Up to $15 Million in Non-Dilutive Growth Capital
Insider Scaled Capital Support Reflects Confidence in Quanome 's Strategic Direction and Future Potential
Quanome CEO to Back Quantum Strategy with Up to $15 Million in Non-Dilutive Growth Capital
Neutral
GlobeNewsWire
1 month ago
Quanome Advances Its AI Cloud Business XDT with US$18.8 Million Infrastructure Purchase Agreement
Company Advances Development of First U.S. AI Infrastructure Hub, Executes Its Quantum & AI Systems Strategy
Quanome Advances Its AI Cloud Business XDT with US$18.8 Million Infrastructure Purchase Agreement
Positive
Benzinga
1 month ago
Quanome Stock Soars 80% After Agreeing to Buy 32 GPU Servers
Quanome Technologies Inc. (NASDAQ:QNME) shares are trading higher Tuesday after the company announced it entered into a Purchase and Sale Agreement and related purchase order with Compal Electronics for the purchase of 32 GPU server units.
Quanome Stock Soars 80% After Agreeing to Buy 32 GPU Servers
Neutral
GlobeNewsWire
2 months ago
Quanome Technologies Establishes Global Quantum Council and Scientific Advisory Network
International expert platforms bring together scientific expertise across four quantum streams to advance understanding, collaboration and real-world application
Quanome Technologies Establishes Global Quantum Council and Scientific Advisory Network
Neutral
GlobeNewsWire
1 year ago
Lakeside Announces Fiscal 2025 Third Quarter and Nine-Month Results
ITASCA, IL, May 15, 2025 (GLOBE NEWSWIRE) -- Lakeside Holding Limited (“Lakeside” or the “Company”) (Nasdaq: LSH), a U.S.-based cross-border supply chain solution provider with a unique focus on the Asia-Pacific market operating through two specialized subsidiaries—American Bear Logistics and Hupan Pharmaceutical (Hubei) Co., Ltd., today announced financial results for its fiscal 2025 third quarter and nine months ended March 31, 2025.
Lakeside Announces Fiscal 2025 Third Quarter and Nine-Month Results
Neutral
PRNewsWire
1 year ago
LAKESIDE HOLDING ANNOUNCES A CONVERTIBLE DEBT FINANCING OF UP TO $4.5 MILLION
ITASCA, Ill. , March 5, 2025 /PRNewswire/ -- Lakeside Holding Limited ("Lakeside" or the "Company") (Nasdaq: LSH), a U.S.-based cross-border supply chain solution provider with a unique focus on the Asia-Pacific market operating through two specialized subsidiaries—American Bear Logistics and Hupan Pharmaceutical (Hubei) Co., Ltd.
LAKESIDE HOLDING ANNOUNCES A CONVERTIBLE DEBT FINANCING OF UP TO $4.5 MILLION
Neutral
PRNewsWire
1 year ago
Lakeside Announces Fiscal 2025 Second Quarter and Six-Month Results
ITASCA, Ill. , Feb. 14, 2025 /PRNewswire/ -- Lakeside Holding Limited ("Lakeside" or the "Company") (Nasdaq: LSH), a U.S.-based cross-border supply chain solution provider with a unique focus on the Asia-Pacific market operating through two specialized subsidiaries—American Bear Logistics and Hupan Pharmaceutical (Hubei) Co., Ltd.
Lakeside Announces Fiscal 2025 Second Quarter and Six-Month Results
Price charts implemented using Lightweight Charts™